Judith Karp

Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ.

On-Line Software International, Inc. provides information technology management software and solutions. The private company is based in Fort Lee, NJ.

The National Science Foundation supports fundamental science and engineering researches. It offers services to people in all scientific and engineering disciplines. The firm focuses on the promotion and progress of science to advance the national health, prosperity and welfare. The company was founded in 1950 and is headquartered in Arlington, VA.

University of Washington functions as a College/University. The company is headquartered in Seattle, WA.

Pansophic Systems, Inc. provides system software and utilities. Its products include Panvalet, a source program and change management system and Easytrieve, a report writer and data retrieval system. The company was founded by Joseph A. Piscopo in 1969 and is located in Lisle, IL

Pilot Software, Inc. develops web-enabled decision support and business intelligence software. The company was founded on August 13, 2002 and is headquartered in Mountain View, CA.

RTI, Inc. operates a holding company. It is engaged in the manufacturing and sale of evaporative coolers, commercial heat exchange modules and high-efficiency air conditioners through its wholly-owned subsidiary Refrigeration Technology, Inc. The company was founded in August 1968 and is headquartered in Sunland Park, NM.

Part of Harris Business Group, Inc., Harris Data Service of Wisconsin, Inc. develops web development software. The company is based in Brookfield, WI.

CHD Bioscience, Inc. develops and manufactures disinfectants for healthcare and food industries. The company is headquartered in Fort Collins, CO.

Armis Biopharma, Inc. is a privately held biopharmaceutical company based in Fort Collins, CO. The company is focused on developing and commercializing products that reduce the risk of infectious disease, decontaminate chemical warfare agents, and provide differentiated medical devices. The company was founded by Edwin D. Neas and has been led by CEO Ted E. Ziemann since 2000.

Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA.

DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX.

Dracen Pharmaceuticals, Inc. develops immuno-metabolism drugs. The company was founded by Barbara Slusher, Jonathan D. Powell, Pavel Majer, and Rana Rais and is headquartered in New York, NY.

Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA.

Ervaxx Ltd. is a British company that pioneers the use of dark antigens to deliver targeted immunotherapies for treating and preventing cancer. The company was founded in 2016 by George Kassiotis, Drew M. Pardoll and is based in London, UK. The company's powerful, proprietary edapt platform has been developed to discover and validate dark antigens providing an in-depth assessment of candidate antigens on primary tumor cells along with their immunogenic potential. Ervaxx is advancing a pipeline of T cell receptor-based therapies, off-the-shelf cancer vaccines, and other immunotherapies leveraging these insights into the role of dark antigens in cancer.

Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York.

Zila, Inc., headquartered in Scottsdale, Arizona and founded in 1988, is a diagnostic company that offers prevention, detection and treatment of oral cancer and periodontal disease. Zila manufactures and markets ViziLite Plus with TBlue (“ViziLite Plus”), the company’s product for the detection of oral abnormalities that could lead to cancer. ViziLite Plus is a medical device for use in a popilation risking for oral cancer. Zila designs, manufactures and markets products sold directly to dental professionals for periodontal disease, including the Rotadent Professional Powered Brush, the Pro-Select Platinum ultrasonic scaler and oral pharmaceutical products for both in-office and home-care use

American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA.

AMAG Pharma USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA.

ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ.

Part of Champions Oncology, Inc., Biomerk, Inc. is a company that owns and operates medical research laboratories. The company is based in Scottsdale, AZ. Biomerk was acquired by Champions Oncology, Inc. on May 18, 2007 for $1.16 million.